Key Points
- Home Depot reported second-quarter sales of $47.86 billion, up 5.7% year over year, exceeding Wall Street expectations.
- Comparable sales increased 1.7% globally and 1.3% in the U.S., supported by demand for smaller repair and maintenance projects despite weak housing activity.
- The company reaffirmed its fiscal 2026 outlook, while elevated mortgage rates, housing affordability pressures, tariffs, and cautious consumer behavior remain key downside risks.
Home Depot delivered better-than-expected second-quarter results while maintaining its full-year financial guidance, highlighting the resilience of home-improvement spending even as the U.S. housing market remains constrained. The results provide an important read-through for investors assessing the intersection of consumer spending, housing activity, interest rates, and corporate earnings, particularly as elevated financing costs continue to discourage major home transactions and large renovation projects.
Smaller Projects Offset Weak Housing Activity
Home Depot reported quarterly revenue of $47.86 billion, a 5.7% increase from a year earlier and above analysts’ expectations of roughly $47.27 billion. Adjusted earnings reached $4.92 per share, also exceeding the $4.73 consensus estimate. Comparable sales increased 1.7% globally and 1.3% in the United States, although customer transactions declined approximately 1%, indicating that higher average spending helped offset softer traffic.
The composition of demand remains particularly important. Consumers have continued spending on relatively smaller projects such as painting, landscaping, patios, plumbing, and maintenance, while higher borrowing costs and elevated home prices have weighed on larger discretionary renovations. This dynamic allows Home Depot to maintain revenue momentum without requiring a broad recovery in housing turnover, but it also underscores the limits of current consumer demand.
Guidance Signals Cautious Confidence
Management maintained its fiscal 2026 outlook, calling for total sales growth of approximately 2.5% to 4.5% and comparable sales growth of approximately flat to 2%. Adjusted diluted earnings per share are expected to grow between flat and 4%. The guidance is consistent with the company’s earlier assessment that the housing environment remains unusually subdued, while the business continues to benefit from repair activity and its growing professional customer base.
The outlook also suggests that a meaningful recovery in large-scale home improvement spending may depend on a broader improvement in housing affordability. Home Depot management has previously described the housing environment as effectively “frozen,” with low turnover and limited activity in areas typically associated with home purchases and sales. Lower mortgage rates could eventually unlock some deferred demand, although the timing and magnitude of such a recovery remain uncertain.
Implications for Global and Israeli Investors
For Israeli investors, Home Depot’s results offer a broader indication of conditions facing the U.S. consumer and housing market, two important components of the global economic cycle. Stronger-than-expected sales suggest that household spending remains relatively resilient, but declining transaction volumes and weak demand for large projects indicate that high financing costs continue to constrain economically sensitive segments.
The company also faces external risks, including tariff-related costs, inflation, labor expenses, and potential changes in consumer confidence. Home Depot has indicated that tariff refunds are expected to help offset some cost pressures, but the sustainability of margins could remain sensitive to changes in input prices and trade policy.
Outlook: The near-term outlook for Home Depot and the broader U.S. home-improvement sector remains cautiously balanced. Resilient repair spending, professional contractor activity, and a potential future easing in mortgage costs could provide support, while persistent housing affordability pressures may continue to delay larger projects. Investors will likely monitor upcoming housing data, mortgage rates, consumer confidence, and Federal Reserve policy signals for evidence that the frozen housing environment is beginning to thaw. Until those indicators improve more decisively, the company’s stable guidance may represent resilience rather than evidence of a broad housing recovery, leaving both upside opportunities and meaningful downside risks in focus.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here
- omer bar
- •
- 8 Min Read
- •
- ago 21 hours
SKN | Could Delta’s Higher Fares Offset Rising Fuel Costs as the Airline Cuts Its 2026 Profit Forecast?
Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge
- ago 21 hours
- •
- 8 Min Read
Delta Air Lines has lowered its 2026 profit expectations as soaring jet fuel costs weigh on earnings, highlighting the challenge
- Ronny Mor
- •
- 6 Min Read
- •
- ago 3 days
SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?
Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is
- ago 3 days
- •
- 6 Min Read
Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is
- Ronny Mor
- •
- 7 Min Read
- •
- ago 5 days
SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?
Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the
- ago 5 days
- •
- 7 Min Read
Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the
- Lior mor
- •
- 8 Min Read
- •
- ago 5 days
SKN | Could Boeing’s New Fighter Jet Wins Mark a Turning Point for Its Defense Business?
Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing
- ago 5 days
- •
- 8 Min Read
Boeing Expands Its Position in Next-Generation Fighters Boeing has strengthened its position in the U.S. military aircraft market after securing